Combined-modality therapy for rectal cancer using irinotecan

被引：0
|
作者：
Minsky, BD
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[2] Cornell Univ, New York, NY USA
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Preoperative or postoperative pelvic radiation plus concurrent fluorouracil-based chemotherapy is standard adjuvant treatment for patients with T3 and/or N1/2 rectal cancer. Newer chemotherapeutic regimens have been developed for the treatment of patients with metastatic disease. Irinotecan (CPT-11, Camptosar)-based regimens have improved survival in patients with metastatic disease and are being actively investigated in combination with pelvic radiation therapy for patients with rectal cancer.
引用
收藏
页码：35 / 38
页数：4
相关论文
共 50 条
  • [21] COMBINED-MODALITY THERAPY OF HEAD AND NECK-CANCER
    STUPP, R
    WEICHSELBAUM, RR
    VOKES, EE
    SEMINARS IN ONCOLOGY, 1994, 21 (03) : 349 - 358
  • [22] Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
    Erta Kalanxhi
    Helga Helseth Hektoen
    Sebastian Meltzer
    Svein Dueland
    Kjersti Flatmark
    Anne Hansen Ree
    BMC Cancer, 16
  • [23] Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
    Kalanxhi, Erta
    Hektoen, Helga Helseth
    Meltzer, Sebastian
    Dueland, Svein
    Flatmark, Kjersti
    Ree, Anne Hansen
    BMC CANCER, 2016, 16 : 1
  • [24] Combined Modality Therapy for Rectal Cancer
    Minsky, Bruce D.
    Roeedel, Claus
    Valentini, Vincenzo
    CANCER JOURNAL, 2010, 16 (03): : 253 - 261
  • [25] Combined Modality Therapy for Rectal Cancer
    Patel, Sagar A.
    Ryan, David P.
    Hong, Theodore S.
    CANCER JOURNAL, 2016, 22 (03): : 211 - 217
  • [26] Integration of novel agents into combined-modality treatment for rectal cancer patients
    Roedel, Claus
    Sauer, Rolf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (05) : 227 - 235
  • [27] The role of UFT in combined-modality therapy
    Blanke, CD
    Teng, M
    Choy, H
    ONCOLOGY-NEW YORK, 1999, 13 (10): : 47 - 54
  • [28] COMBINED-MODALITY THERAPY OF CANCER - WHAT IS IT AND WHEN DOES IT WORK
    ROSENBERG, SA
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (23): : 1512 - 1514
  • [29] Docetaxel and radiation as combined-modality therapy
    Kim, ES
    Khuri, FR
    ONCOLOGY-NEW YORK, 2002, 16 (06): : 97 - 105
  • [30] Carcinomatous meningitis secondary to breast cancer: Combined-modality therapy
    Chamberlain, MC
    Kormanik, P
    ANNALS OF NEUROLOGY, 1996, 40 (03) : M8 - M8
12345